Biogen (BIIB) Surges Amid Rumors of Acquisition by Samsung – Nasdaq

Biogen (BIIB) Surges Amid Rumors of Acquisition by Samsung  Nasdaq Biogen retrace gains after Samsung rejected deal talks (NASDAQ:BIIB)  Seeking Alpha Biogen Stock (BIIB): $502 Price Target From Truist  Pulse 2.0 Biogen Down 8% on Denied Rumours of Acquisition from Samsung  AskTraders Biogen stock surges 10% on report of possible sale  WRAL TechWire View Full Coverage on Google News Go to Source Author: